GLP-1 Medications May Improve Health in People With PAD and Diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists may reduce hospitalizations, amputations, and deaths among people with peripheral artery disease (PAD) and type 2 diabetes compared with metformin, a new study suggests.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.